Ibopamine (BioDeep_00000023983)

   

human metabolite natural product


代谢物信息卡片


[4-[2-(methylamino)ethyl]-2-(2-methylpropanoyloxy)phenyl] 2-methylpropanoate

化学式: C17H25NO4 (307.178349)
中文名称: 异波帕胺
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CC(C)C(=O)OC1=C(C=C(C=C1)CCNC)OC(=O)C(C)C
InChI: InChI=1S/C17H25NO4/c1-11(2)16(19)21-14-7-6-13(8-9-18-5)10-15(14)22-17(20)12(3)4/h6-7,10-12,18H,8-9H2,1-5H3

描述信息

Ibopamine is a sympathomimetic used in ophthalmology. It induces mydriasis. It also has been investigated for use in the treatment of congestive heart failure.
C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents
S - Sensory organs > S01 - Ophthalmologicals > S01F - Mydriatics and cycloplegics > S01FB - Sympathomimetics excl. antiglaucoma preparations
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists
C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist
D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents
D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
D020011 - Protective Agents > D002316 - Cardiotonic Agents
D045283 - Natriuretic Agents > D004232 - Diuretics

同义名列表

9 个代谢物同义名

[4-[2-(methylamino)ethyl]-2-(2-methylpropanoyloxy)phenyl] 2-methylpropanoate; 5-[2-(methylamino)ethyl]-2-[(2-methylpropanoyl)oxy]phenyl 2-methylpropanoate; Propanoic acid, 2-methyl-, 4-(2-(methylamino)ethyl)-1,2-phenylene ester; N-Methyldopamine diisobutyrate; Ibopamine hydrochloride; Escandine; Ibopamine; Inopamil; SB 7505



数据库引用编号

10 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

9 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Chunyu Zeng, Robin A Felder, Pedro A Jose. A new approach for treatment of hypertension: modifying D1 dopamine receptor function. Cardiovascular & hematological agents in medicinal chemistry. 2006 Oct; 4(4):369-77. doi: 10.2174/187152506778520727. [PMID: 17073613]
  • Sheila A Doggrell. The therapeutic potential of dopamine modulators on the cardiovascular and renal systems. Expert opinion on investigational drugs. 2002 May; 11(5):631-44. doi: 10.1517/13543784.11.5.631. [PMID: 11996645]
  • H L Hillege, A R Girbes, P J de Kam, F Boomsma, D de Zeeuw, A Charlesworth, J R Hampton, D J van Veldhuisen. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 2000 Jul; 102(2):203-10. doi: 10.1161/01.cir.102.2.203. [PMID: 10889132]
  • J Feenstra, B A in't Veld, P D van der Linden, D E Grobbee, B H Stricker. Risk factors for mortality in users of ibopamine. British journal of clinical pharmacology. 1998 Jul; 46(1):71-7. doi: 10.1046/j.1365-2125.1998.00046.x. [PMID: 9690952]
  • K M Yee, A D Struthers. Can drug effects on mortality in heart failure be predicted by any surrogate measure?. European heart journal. 1997 Dec; 18(12):1860-4. doi: 10.1093/oxfordjournals.eurheartj.a015193. [PMID: 9447312]
  • B H Stricker, J Feenstra, J P Ottervanger, A J Porsius, D E Grobbee. A nested case-control study on mortality in users of ibopamine. The Netherlands journal of medicine. 1997 Nov; 51(5):163-8. doi: 10.1016/s0300-2977(97)00053-3. [PMID: 9455095]
  • A C Teisman, D J van Veldhuisen, E Scholtens, W Maselbas, W H van Gilst. Effects of selective dopaminergic receptor stimulation on ventricular remodeling after experimental myocardial infarction in rats. Journal of cardiac failure. 1997 Sep; 3(3):199-205. doi: 10.1016/s1071-9164(97)90016-6. [PMID: 9330128]
  • H Buikema, D J van Veldhuisen, H Hegeman, W H van Gilst. Early pharmacologic intervention may prevent the deterioration in endothelial function after experimental myocardial infarction in rats: effects of ibopamine and captopril. Journal of cardiac failure. 1997 Jun; 3(2):125-32. doi: 10.1016/s1071-9164(97)90046-4. [PMID: 9220312]
  • R Andrews, A Charlesworth, A Evans, A J Cowley. A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure. European heart journal. 1997 May; 18(5):852-7. doi: 10.1093/oxfordjournals.eurheartj.a015351. [PMID: 9152656]
  • B M Szabó, D J van Veldhuisen, P H van der Burgh, J Kruik, A R Girbes, K I Lie. Clinical and autonomic effects of ibopamine as adjunct to angiotensin-converting enzyme inhibitors in chronic heart failure. Journal of cardiac failure. 1996 Sep; 2(3):185-92. doi: 10.1016/s1071-9164(96)80040-6. [PMID: 8891856]
  • S Stefoni, G Mosconi, G La Manna, V Bonomini, V Mioli, E Fanciulli, C Feletti, D Docci, P Cappelli, M Bonomini, F Locatelli, P Marai, G Bazzato, A Fracasso, D Brancaccio, C Galmozzi, L Scarpioni, E Sverzellati, G B Sorba, M Cossu, G Piccoli, D Roccatello, L Oldrizzi, V De Biase, A A Bignamini. Low-dosage ibopamine treatment in progressive renal failure: a long-term multicentre trial. American journal of nephrology. 1996; 16(6):489-99. doi: 10.1159/000169049. [PMID: 8955760]
  • L Dei Cas, M Metra, S Nodari, D Raccagni. [Clinical efficacy of oral dopaminergic agents: new findings]. Cardiologia (Rome, Italy). 1995 Dec; 40(12 Suppl 1):131-8. doi: NULL. [PMID: 8998705]
  • J Brouwer, D J van Veldhuisen, A J Man in 't Veld, P H Dunselman, F Boomsma, J Haaksma, K I Lie. Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group. Journal of the American College of Cardiology. 1995 Oct; 26(4):983-90. doi: 10.1016/0735-1097(95)00285-3. [PMID: 7560628]
  • D J van Veldhuisen, O E Brodde, W H van Gilst, C Schulze, H Hegeman, R L Anthonio, E Scholtens, P A de Graeff, H Wesseling, K I Lie. Relation between myocardial beta-adrenoceptor density and hemodynamic and neurohumoral changes in a rat model of chronic myocardial infarction: effects of ibopamine and captopril. Cardiovascular research. 1995 Sep; 30(3):386-93. doi: 10.1016/s0008-6363(95)00058-5. [PMID: 7585830]
  • A G Lieverse, A R Girbes, D J Van Veldhuisen, A J Smit, J G Zijlstra, S Meijer, K I Lie, W D Reitsma. The effects of ibopamine on glomerular filtration rate and plasma norepinephrine remain preserved during prolonged treatment in patients with congestive heart failure. European heart journal. 1995 Jul; 16(7):937-42. doi: 10.1093/oxfordjournals.eurheartj.a061028. [PMID: 7498209]
  • M Metra, C Missale, P F Spano, L D Cas. Dopaminergic drugs in congestive heart failure: hemodynamic and neuroendocrine responses to ibopamine, dopamine, and dihydroergotoxine. Journal of cardiovascular pharmacology. 1995 May; 25(5):732-40. doi: 10.1097/00005344-199505000-00008. [PMID: 7630152]
  • D J van Veldhuisen, J Brouwer, A J Man in 't Veld, P H Dunselman, F Boomsma, K I Lie. Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin as monotherapy. DIMT Study Group. Dutch Ibopamine Multicenter Trial. The American journal of cardiology. 1995 Apr; 75(12):796-800. doi: 10.1016/s0002-9149(99)80414-7. [PMID: 7717282]
  • H Pouleur. Neurohormonal and hemodynamic effects of ibopamine. Clinical cardiology. 1995 Mar; 18(3 Suppl I):I17-21. doi: 10.1002/clc.4960181306. [PMID: 7743694]
  • A G Lieverse, D J van Veldhuisen, A J Smit, J G Zijlstra, S Meijer, W D Reitsma, K I Lie, A R Girbes. Renal and systemic hemodynamic effects of ibopamine in patients with mild to moderate congestive heart failure. Journal of cardiovascular pharmacology. 1995 Mar; 25(3):361-7. doi: 10.1097/00005344-199503000-00003. [PMID: 7769799]
  • M Metra, L Dei Cas. Clinical efficacy of ibopamine in patients with chronic heart failure. Clinical cardiology. 1995 Mar; 18(3 Suppl I):I22-31. doi: 10.1002/clc.4960181307. [PMID: 7743695]
  • A R Girbes, A R Milner, B V McCloskey, J H Zwaveling, D J van Veldhuisen, J G Zijlstra, K I Lie. Oral ibopamine substitution in patients with intravenous dopamine dependence. Cardiology. 1995; 86(5):391-5. doi: 10.1159/000176908. [PMID: 7585741]
  • W H van Gilst, D J van Veldhuisen, H Hegeman, H Buikema, E Scholtens, P A de Graeff, K I Lie. Effect of ibopamine on ventricular remodeling after experimental myocardial infarction: a comparison with captopril. Journal of cardiovascular pharmacology. 1994 Jul; 24(1):171-4. doi: 10.1097/00005344-199407000-00026. [PMID: 7521484]
  • D J van Veldhuisen, W H van Gilst, B J de Smet, P A de Graeff, E Scholtens, H Buikema, A R Girbes, H Wesseling, K I Lie. Neurohumoral and hemodynamic effects of ibopamine in a rat model of chronic myocardial infarction and heart failure. Cardiovascular drugs and therapy. 1994 Apr; 8(2):245-50. doi: 10.1007/bf00877333. [PMID: 7918137]
  • M F Rousseau, M A Konstam, C R Benedict, J Donckier, L Galanti, J Melin, D Kinan, S Ahn, J M Ketelslegers, H Pouleur. Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor. The American journal of cardiology. 1994 Mar; 73(7):488-93. doi: 10.1016/0002-9149(94)90680-7. [PMID: 7908164]
  • H Buikema, W H van Gilst, D J van Veldhuisen, B J de Smet, E Scholtens, K I Lie, H Wesseling. Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine. Cardiovascular research. 1993 Dec; 27(12):2118-24. doi: 10.1093/cvr/27.12.2118. [PMID: 8313417]
  • D J van Veldhuisen, A J Man in 't Veld, P H Dunselman, D J Lok, H J Dohmen, J C Poortermans, A J Withagen, W H Pasteuning, J Brouwer, K I Lie. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT). Journal of the American College of Cardiology. 1993 Nov; 22(6):1564-73. doi: 10.1016/0735-1097(93)90579-p. [PMID: 7901256]
  • P L Rensma, A H van den Meiracker, F Boomsma, A J Man in 't Veld, M A Schalekamp. Effects of ibopamine on postural hypotension in pure autonomic failure. Journal of cardiovascular pharmacology. 1993 Jun; 21(6):863-8. doi: 10.1097/00005344-199306000-00003. [PMID: 7687709]
  • D J van Veldhuisen, A R Girbes, S A van den Broek, P A de Graeff, W H van Gilst, K I Lie. Effects of ibopamine on the increase in plasma norepinephrine levels during exercise in congestive heart failure. The American journal of cardiology. 1993 Apr; 71(11):992-4. doi: 10.1016/0002-9149(93)90920-8. [PMID: 8465795]
  • A R Girbes, C J Kalisvaart, D J Van Veldhuisen, E T Tan, A J Smit, W D Reitsma, W H Pasteuning. Effects of ibopamine on renal haemodynamics in patients with severe congestive heart failure. European heart journal. 1993 Feb; 14(2):279-83. doi: 10.1093/eurheartj/14.2.279. [PMID: 8095455]
  • O E Brodde, I Klusmann, M Wojcik, A J Man in't Veld, F Boomsma, M C Michel. Lack of desensitization of alpha- and beta-adrenoceptor function during chronic treatment of healthy volunteers with ibopamine, an orally active dopamine receptor agonist. European journal of clinical pharmacology. 1993; 44(3):283-6. doi: 10.1007/bf00271373. [PMID: 8098281]
  • L Dei Cas, M Metra, O Visioli. Effects of acute and chronic ibopamine administration on resting and exercise hemodynamics, plasma catecholamines and functional capacity of patients with chronic congestive heart failure. The American journal of cardiology. 1992 Sep; 70(6):629-34. doi: 10.1016/0002-9149(92)90203-b. [PMID: 1354938]
  • A R Girbes, D J Van Veldhuisen, A J Smit. [New dopamine agonists in cardiovascular therapy]. Presse medicale (Paris, France : 1983). 1992 Aug; 21(27):1287-91. doi: NULL. [PMID: 1359528]
  • A R Girbes, D J Van Veldhuisen, R G Grevink, A J Smith, W D Reitsma. Effects of ibopamine on exercise-induced increase in norepinephrine in normal men. Journal of cardiovascular pharmacology. 1992 Mar; 19(3):371-4. doi: 10.1097/00005344-199203000-00011. [PMID: 1378116]
  • M F Rousseau, J Raigoso, C van Eyll, H Van Mechelen, N R Musso, G Lotti, H Pouleur. Effects of intravenous epinine administration on left ventricular systolic performance, coronary hemodynamics, and circulating catecholamines in patients with heart failure. Journal of cardiovascular pharmacology. 1992 Feb; 19(2):155-62. doi: 10.1097/00005344-199202000-00001. [PMID: 1376782]
  • D J Van Veldhuisen, H J Crijns, A R Girbes, T J Tobé, A C Wiesfeld, K I Lie. Electrophysiologic profile of ibopamine in patients with congestive heart failure and ventricular tachycardia and relation to its effects on hemodynamics and plasma catecholamines. The American journal of cardiology. 1991 Nov; 68(11):1194-202. doi: 10.1016/0002-9149(91)90193-o. [PMID: 1683146]
  • H Pouleur, J Raigoso, M F Rousseau. Dopaminergic drugs in the management of chronic heart failure. European heart journal. 1991 Aug; 12 Suppl C(?):29-34. doi: 10.1093/eurheartj/12.suppl_c.29. [PMID: 1680685]
  • A R Girbes, D J van Veldhuisen, A J Smit. Dopamine agonists, a new perspective in cardiovascular therapy?. The Netherlands journal of medicine. 1991 Aug; 39(1-2):65-71. doi: NULL. [PMID: 1683693]
  • A R Girbes, D J van Veldhuisen, A J Smit, A Drent-Bremer, S Meijer, W D Reitsma. Renal and neurohumoral effects of ibopamine and metoclopramide in normal man. British journal of clinical pharmacology. 1991 Jun; 31(6):701-4. doi: 10.1111/j.1365-2125.1991.tb05597.x. [PMID: 1678273]
  • H Itoh. Clinical pharmacology of ibopamine. The American journal of medicine. 1991 May; 90(5B):36S-42S. doi: 10.1016/0002-9343(91)90272-y. [PMID: 1675550]
  • J López-Sendón. Ibopamine in chronic congestive heart failure: hemodynamic and neurohumoral effects. The American journal of medicine. 1991 May; 90(5B):43S-49S. doi: 10.1016/0002-9343(91)90273-z. [PMID: 1675551]
  • A J Man in't Veld. Ibopamine in the treatment of heart failure. The American journal of medicine. 1991 May; 90(5B):50S-54S. doi: 10.1016/0002-9343(91)90274-2. [PMID: 1675552]
  • U Borchard. [Ibopamine--pharmacologic principles]. Zeitschrift fur Kardiologie. 1991; 80 Suppl 8(?):63-6. doi: . [PMID: 1686693]
  • M Wehling, K Theisen. [Ibopamine--acute hemodynamic, renal and neurohumoral effects]. Zeitschrift fur Kardiologie. 1991; 80 Suppl 8(?):67-9. doi: NULL. [PMID: 1686694]
  • D J Van Veldhuisen, A R Girbes, H J Crijns, A J Smit, W H Van Gilst, K I Lie. The oral dopamine agonist, ibopamine, in normal man: effects on rhythm, heart rate, blood pressure and catecholamines. International journal of clinical pharmacology research. 1991; 11(3):159-65. doi: NULL. [PMID: 1687321]
  • F X Kleber. [Ibopamine--clinical results]. Zeitschrift fur Kardiologie. 1991; 80 Suppl 8(?):71-6. doi: NULL. [PMID: 1686695]
  • S H Taylor, V Cicchetti. Efficacy of ibopamine in the treatment of heart failure. American heart journal. 1990 Dec; 120(6 Pt 2):1583-90. doi: 10.1016/0002-8703(90)90063-4. [PMID: 1978982]
  • R J Kasmer, R E Cutler, M A Munger, R C Jarvis, D Hricik, A R Nara, P Goldberg, J A Green. Single-dose effects of ibopamine hydrochloride on renal function in patients with congestive heart failure. British journal of clinical pharmacology. 1990 Sep; 30(3):485-9. doi: 10.1111/j.1365-2125.1990.tb03802.x. [PMID: 2223427]
  • H Taniguchi, T Iwasaka, T Sugiura, Y Takayama, T Sumimoto, H Onoyama, H Takashima, S Nakamura, M Inada. Hemodynamic response to ibopamine in acute myocardial infarction. Arzneimittel-Forschung. 1990 Apr; 40(4):428-31. doi: NULL. [PMID: 2357243]
  • M Wehling, J Zimmermann, J Weil, R Gerzer, K Theisen. [Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure]. Zeitschrift fur Kardiologie. 1990 Feb; 79(2):120-5. doi: NULL. [PMID: 2157313]
  • C Casagrande, L Merlo, A La Regina. Development of dopaminergic drugs for the chronic treatment of congestive heart failure. Journal of autonomic pharmacology. 1990; 10 Suppl 1(?):s85-93. doi: 10.1111/j.1474-8673.1990.tb00233.x. [PMID: 1983011]
  • F Salerno, P Incerti, S Badalamenti, E Lorenzano, G Graziani, A Morganti, P Ghirardi. Renal and humoral effects of ibopamine, a dopamine agonist, in patients with liver cirrhosis. Archives of internal medicine. 1990 Jan; 150(1):65-9. doi: NULL. [PMID: 1967522]
  • S Caponnetto, V Terrachini, C Canale, F Bruzzone, M A Masperone, L Pastorino, L Licciardello, G V Marchetti. Long-term treatment of congestive heart failure with oral ibopamine. Effects of rhythm disorders and neurohormonal alterations. Cardiology. 1990; 77 Suppl 5(?):43-8. doi: 10.1159/000174695. [PMID: 1980633]
  • J López-Sendón. Hemodynamic and neurohumoral effects of ibopamine in patients with chronic congestive heart failure. Cardiology. 1990; 77 Suppl 5(?):9-21. doi: 10.1159/000174690. [PMID: 1980634]
  • D J van Veldhuisen, A R Girbes, H J Crijns, A J Smit, P A de Graeff, K I Lie. Efficacy and safety of ibopamine in congestive heart failure. Journal of autonomic pharmacology. 1990; 10 Suppl 1(?):s115-21. doi: 10.1111/j.1474-8673.1990.tb00237.x. [PMID: 1983005]
  • C Holubarsch, H Just. The safety profile of ibopamine, an alternative substance for treatment of chronic heart failure. Cardiology. 1990; 77 Suppl 5(?):1-8. doi: 10.1159/000174689. [PMID: 2279251]
  • P Marchetti, F Sabino, R Giannarelli, A DiCarlo, V Cicchetti, R Navalesi. Safety of ibopamine in type II diabetic patients with mild chronic heart failure. A double-blind cross-over study. Cardiology. 1990; 77 Suppl 5(?):57-62. doi: 10.1159/000174697. [PMID: 2279253]
  • M Wehling, J Zimmermann, K Theisen. Extracardial effects of oral ibopamine versus furosemide in patients with mild or moderate heart failure. A double-blind, randomized trial. Cardiology. 1990; 77 Suppl 5(?):81-8. doi: 10.1159/000174701. [PMID: 2279257]
  • C Nappi, G Colace, P Affinito, M Taglialatela, G F Di Renzo, U Montemagno, L Annunziato. Ibopamine-induced reduction of serum prolactin level and milk secretion in puerperal women. European journal of clinical pharmacology. 1990; 39(2):133-5. doi: 10.1007/bf00280046. [PMID: 2253662]
  • S Stefoni, G Mosconi, M Bonomini, R Prandini, A Nanni-Costa, M P Scolari, G Liviano-D'Arcangelo, G Cianciolo. The use of ibopamine in chronic renal failure: long-term results. Contributions to nephrology. 1990; 81(?):264-9. doi: 10.1159/000418762. [PMID: 2093507]
  • C de Mey, D Enterling, I Meineke. Pharmacokinetic and pharmacodynamic interactions between single oral doses of ibopamine and food in normal man. Arzneimittel-Forschung. 1989 Sep; 39(9):1138-43. doi: NULL. [PMID: 2590265]
  • L Dei Cas, M Metra, S Nodari, O Visioli. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations. Journal of cardiovascular pharmacology. 1989; 14 Suppl 8(?):S111-7. doi: . [PMID: 2483436]
  • C Casagrande, L Merlo, R Ferrini, G Miragoli, C Semeraro. Cardiovascular and renal action of dopaminergic prodrugs. Journal of cardiovascular pharmacology. 1989; 14 Suppl 8(?):S40-59. doi: . [PMID: 2483441]
  • G Hasenfuss, H Just. Clinical relevance of long-term therapy with levodopa and orally active dopamine analogues in patients with chronic congestive heart failure. Basic research in cardiology. 1989; 84 Suppl 1(?):191-6. doi: 10.1007/bf02650359. [PMID: 2573341]
  • C Missale, M Metra, S Sigala, M Memo, L Dei Cas, P F Spano. Inhibition of aldosterone secretion by dopamine, ibopamine, and dihydroergotoxine in patients with congestive heart failure. Journal of cardiovascular pharmacology. 1989; 14 Suppl 8(?):S72-6. doi: NULL. [PMID: 2483443]
  • E Riva, A Cavalli, G Abbondati, M C Cedrini, M Schleman, L M Fuccella. Ibopamine: long-term safety study in patients with congestive heart failure. The Italian Ibopamine Working Group. International journal of clinical pharmacology research. 1989; 9(1):21-8. doi: NULL. [PMID: 2707922]
  • C Sala, A Morganti, P Ferraris, G Ardeleani, P Venegoni, P Quorso, B Ambrosi, A Zanchetti. Dopaminergic control of aldosterone secretion is not mediated by atrial natriuretic factor in patients with essential hypertension. Journal of hypertension. Supplement : official journal of the International Society of Hypertension. 1988 Dec; 6(4):S336-8. doi: 10.1097/00004872-198812040-00104. [PMID: 2977175]
  • F Azzollini, L De Caro, A Longo, G Pelosi, E Rolandi, G P Ventresca, E Lodola. Ibopamine kinetics after single and multiple dosing in patients with congestive heart failure. International journal of clinical pharmacology, therapy, and toxicology. 1988 Nov; 26(11):544-51. doi: . [PMID: 3243658]
  • G Y Kuo, B Y Hwang, R K Lynn. Identification of ibopamine metabolites in rat and dog urine. Drug metabolism and disposition: the biological fate of chemicals. 1988 Nov; 16(6):793-8. doi: . [PMID: 2907455]
  • J Douchamps, M Juvent, K Vanschoubroek, A Seth, F Deger, F Derenne, A Herchuelz. Study of the bioequivalence of three oral formulations of ibopamine in healthy volunteers. International journal of clinical pharmacology, therapy, and toxicology. 1988 Oct; 26(10):482-6. doi: NULL. [PMID: 3069751]
  • G P Ventresca, E Lodola. Clinical pharmacokinetics of ibopamine on different diseases and conditions. Arzneimittel-Forschung. 1988 Aug; 38(8):1175-80. doi: . [PMID: 2904270]
  • E Vitolo, G Segalini, L Carini, D Castini, A Moreo, C Mazzola, S Segagni, G Villa, A Salvadeo. Effects of ibopamine in combination with furosemide on renal function in patients with chronic congestive heart failure. International journal of clinical pharmacology, therapy, and toxicology. 1988 Jul; 26(7):327-34. doi: NULL. [PMID: 3209280]
  • A Salvadeo, G Villa, G Bovio, F Pocchiari, R Pataccini, A Longo, G P Ventresca. Pharmacokinetics of ibopamine in patients with renal impairment. International journal of clinical pharmacology, therapy, and toxicology. 1988 Feb; 26(2):98-104. doi: . [PMID: 3410592]
  • F Azzollini, G Cattò, G Iacuitti, G Pelosi, M Picca, F Pocchiari, R Pataccini, P Castelnovo, A Longo, G P Ventresca. Ibopamine kinetics after a single oral dose in patients with congestive heart failure. International journal of clinical pharmacology, therapy, and toxicology. 1988 Feb; 26(2):105-12. doi: NULL. [PMID: 3410586]
  • J Partanen, M S Nieminen, H Lehto. Effect of ibopamine on the failing heart at rest and during isometric exercise: a noninvasive study. Clinical cardiology. 1988 Jan; 11(1):15-22. doi: 10.1002/clc.4960110112. [PMID: 3349658]
  • W D Bussmann, K Wienhöfer, R Frik. Ibopamine--how should it be used?. Cardiology. 1988; 75 Suppl 1(?):126-37. doi: 10.1159/000174452. [PMID: 3069210]
  • J Tarján. Dopamine agonists for oral use. Therapia Hungarica (English edition). 1988; 36(4):182-90. doi: NULL. [PMID: 2908160]
  • A J Nichols, R J Shebuski, R R Ruffolo. Inhibition of plasma cholinesterase prevents the dopamine DA-1 receptor mediated renal vasodilation produced by ibopamine. European journal of pharmacology. 1987 Sep; 141(3):515-8. doi: 10.1016/0014-2999(87)90577-2. [PMID: 3666046]
  • S C Scott, J Locke-Haydon, N S Pready, N P Buller, R J Cregeen. Ibopamine (SK&F 100168) pharmacokinetics in relation to the timing of meals. British journal of clinical pharmacology. 1987 May; 23(5):585-7. doi: 10.1111/j.1365-2125.1987.tb03095.x. [PMID: 3593628]
  • T Nakano, N Isaka, T Konishi, H Tekezawa, Y Morimoto, Y Kakuta, T Kodera, M Kanamaru. [Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure]. Kokyu to junkan. Respiration & circulation. 1987 May; 35(5):553-9. doi: NULL. [PMID: 3112884]
  • G C Agnoli, R Borgatti, M Cacciari, S Dorigoni, C Garutti, E Ikonomu, P Lenzi. [Ibopamine, adrenolytic drugs and renal function]. Minerva cardioangiologica. 1987 May; 35(5):241-50. doi: NULL. [PMID: 2888053]
  • T Nakano, Y Morimoto, Y Kakuta, T Konishi, T Kodera, M Kanamaru, H Takezawa. Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure. Arzneimittel-Forschung. 1986 Dec; 36(12):1829-34. doi: NULL. [PMID: 3551968]
  • D Docci, E Pistocchi, F Turci, L Baldrati. Effect of ibopamine on the progression of chronic renal failure. Clinical nephrology. 1986 Sep; 26(3):121-4. doi: NULL. [PMID: 3769226]
  • R Gifford, W C Randolph, F C Heineman, J A Ziemniak. Analysis of epinine and its metabolites in man after oral administration of its pro-drug ibopamine using high-performance liquid chromatography with electrochemical detection. Journal of chromatography. 1986 Aug; 381(1):83-93. doi: 10.1016/s0378-4347(00)83567-7. [PMID: 3771727]
  • S I Rajfer, J D Rossen, F L Douglas, L I Goldberg, T Karrison. Effects of long-term therapy with oral ibopamine on resting hemodynamics and exercise capacity in patients with heart failure: relationship to the generation of N-methyldopamine and to plasma norepinephrine levels. Circulation. 1986 Apr; 73(4):740-8. doi: 10.1161/01.cir.73.4.740. [PMID: 3948372]
  • P L Incerti, S Badalamenti, E Lorenzano, G Graziani, A Morganti, F Salerno, P Ghirardi. Humoral and renal effects of ibopamine in normal subjects. Arzneimittel-Forschung. 1986 Feb; 36(2A):405-7. doi: . [PMID: 3518727]
  • G Miragoli, R Ferrini. Effect of ibopamine on diuresis in conscious rats in normal and experimentally altered conditions. Arzneimittel-Forschung. 1986 Feb; 36(2A):318-22. doi: . [PMID: 3707642]
  • F Pocchiari, R Pataccini, P Castelnovo, A Longo, C Casagrande. Ibopamine, an orally active dopamine-like drug: metabolism and pharmacokinetics in rats. Arzneimittel-Forschung. 1986 Feb; 36(2A):334-40. doi: . [PMID: 3707645]
  • F Pocchiari, R Pataccini, P Castelnovo, A Longo, M Paro, C Casagrande. Ibopamine, an orally active dopamine-like drug: metabolism and pharmacokinetics in dogs. Arzneimittel-Forschung. 1986 Feb; 36(2A):341-4. doi: . [PMID: 3707646]
  • E Lodola, M Borgia, A Longo, F Pocchiari, R Pataccini, D Sher. Ibopamine kinetics after a single oral dose in healthy volunteers. Arzneimittel-Forschung. 1986 Feb; 36(2A):345-8. doi: NULL. [PMID: 3707647]
  • C De Vita, E Triulzi, S Devizzi, G Colombo, M Palvarini, F Pocchiari, R Pataccini. Evaluation of acute hemodynamic effects and pharmacokinetic behaviour of ibopamine in patients with severe heart failure. Arzneimittel-Forschung. 1986 Feb; 36(2A):349-54. doi: NULL. [PMID: 3707648]
  • R Ferrini, G Miragoli. Activity of ibopamine on some isolated organs. Arzneimittel-Forschung. 1986 Feb; 36(2A):312-7. doi: NULL. [PMID: 3458467]
  • C Casagrande, F Santangelo, C Saini, F Doggi, F Gerli, O Cerri. Synthesis and chemical properties of ibopamine and of related esters of N-substituted dopamines--synthesis of ibopamine metabolites. Arzneimittel-Forschung. 1986 Feb; 36(2A):291-303. doi: NULL. [PMID: 3707640]
  • A Cadel, B Brusoni, P Pirelli, G Osculati, A Rovati, R Fanciulli, L Carati, F Valagussa. Effects of digoxin, placebo and ibopamine on exercise tolerance and cardiac rhythm of patients with chronic post-infarct left ventricular failure. Arzneimittel-Forschung. 1986 Feb; 36(2A):376-9. doi: NULL. [PMID: 3707653]
  • L Merlo, P Ghirardi, B Brusoni, E Mussini, G Marchetti. Effects of ibopamine on systemic, pulmonary and regional hemodynamics. Experimental investigations in anesthetized dogs. Arzneimittel-Forschung. 1986 Feb; 36(2A):304-11. doi: NULL. [PMID: 3707641]
  • K E Britton, M K Nawaz, C C Nimmon, E Mlodkowska, M Carroll, T Horne, M Granowska. Total and intrarenal flow distribution in healthy subjects: technique, acute effects of ibopamine and of indoramin. Nephron. 1986; 43(4):265-73. doi: 10.1159/000183852. [PMID: 3736737]
  • E Rolandi, G Marchetti, R Franceschini, V Cicchetti, R Gianrossi, V Cantoni, T Barreca. Inhibition of prolactin and aldosterone secretion by the dopamine derivative ibopamine. European journal of clinical pharmacology. 1986; 29(5):629-30. doi: 10.1007/bf00635905. [PMID: 3956568]
  • N Marchionni, A Conti, W De Alfieri, M Di Bari, L Ferrucci, A Lombardi, G Moschi, A Vannucci. Ibopamine in congestive heart failure refractory to digitalis, diuretics, and captopril. Journal of clinical pharmacology. 1986 Jan; 26(1):74-7. doi: 10.1002/j.1552-4604.1986.tb02907.x. [PMID: 3512618]
  • K Kawahara, J Inui. Analysis of the positive inotropic effect of ibopamine in the blood-perfused canine papillary muscle. Journal of cardiovascular pharmacology. 1985 Mar; 7(2):316-20. doi: 10.1097/00005344-198503000-00017. [PMID: 2581086]
  • G C Agnoli, M Cacciari, A Cariani, C Garutti, E Ikonomu, P Lenzi. [Effect of ibopamine on the renal functional response to extracellular volume expansion in man]. Cardiologia (Rome, Italy). 1985 Feb; 30(2):129-37. doi: NULL. [PMID: 4064065]